Steven Bailey
Interventional Cardiology · Shreveport, LANPI 1003921909
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $279,626 of the $305,384 with a category attached, or 91.6%. Abbott accounts for 76.5% of it on its own, with 20 other manufacturers making up the rest. Among interventional cardiology clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 207 payments — averaging $1475.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$234K
- Jenavalve Technology, Inc.$52K
- Boston Scientific$19K
- Medtronic$587
- Edwards Lifesciences$123
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$100
- plus $654 from 15 others
Across 3 payments — averaging $1008.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Edwards Lifesciences$3K
What the payments were for
- Consulting fees$279,62692%
- Speaking & faculty fees$15,6885%
- Travel & lodging$7,7253%
- Food & beverage$2,3461%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 121 | $233,645 |
| Jenavalve Technology, Inc. | 16 | $51,698 |
| Boston Scientific | 13 | $18,578 |
| Medtronic(2 entities) | 23 | $587 |
| Edwards Lifesciences | 3 | $123 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $100 |
| Novartis | 5 | $97 |
| Johnson & Johnson | 5 | $91 |
| Osprey Medical Inc | 1 | $89 |
| Biotronik Inc. | 2 | $86 |
| Cvrx, Inc. | 1 | $72 |
| Vifor Pharma, Inc. | 1 | $35 |
| Pfizer | 2 | $29 |
| GE HealthCare | 1 | $25 |
| Mallinckrodt Hospital Products Inc. | 1 | $23 |
| Siemens Medical Solutions USA, Inc. | 1 | $22 |
| Boehringer Ingelheim | 1 | $20 |
| Calliditas Therapeutics US Inc. | 1 | $19 |
| Catheter Precision, Inc. FKA Ra Medical Systems, Inc. | 1 | $17 |
| Quidel Corporation | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MitraClip$105,125
- AMPLATZER Occluders$60,540
- AMPLATZER AMULET$41,750
- JenaValve Pericardial TAVR System$30,425
- CLINICAL TRIAL PRODUCT$13,688
- JETi All In One Non-Sterile Kit$9,500
- MitraClip System$7,125
- CoreValve Evolut$374
How this compares
$305,384 in reported general payments places this provider in the 95th percentile of 171 interventional cardiology providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 13 | $77 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Shreveport
- Tarek HelmyShreveport$46K
- James SmithShreveport$31K
- Eric ReevesShreveport$27K
- Boshra LoukaShreveport$23K
- Pavan KatikaneniShreveport$20K
- George MinaShreveport$19K
- Paul DavisShreveport$16K
- Craig WalkerHouma$5M
- Denzil MoraesBaton Rouge$901K
- Ankur LodhaLafayette$640K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.